Furthermore, among 668 participants administered with once-daily IDegAsp in four studies [25,26,27,28] and 677 participants administered with once-daily basal insulin, 77 (11.5%) and 129 (19.1%) demonstrated at least one nocturnal confirmed hypoglycemia event, respectively. The gene discussed is INS; the disease is Hypoglycemia.